Table of Contents

Investment Opportunities in the Home Healthcare

The global home healthcare market is projected to reach USD 383.0 Billion by 2028 from USD 250.0 Billion in 2023, at a CAGR of 8.9%
home healthcare market

The global home healthcare market is poised to achieve significant growth, expected to soar to USD 383.0 Billion by 2028 from USD 250.0 Billion in 2023, indicating a robust CAGR of 8.9% during the forecast period. This growth trajectory is primarily propelled by the expanding elderly population and the increasing prevalence of chronic ailments.

Key Market Players:

Leading players in the market include Fresenius SE & Co. KGaA (Germany), Abbott (US), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), ResMed, Inc. (US), among others. These key industry participants are strategically employing various tactics to steer the global growth trajectory of the home healthcare sector.

Download a PDF Brochure:

Fresenius SE & Co. KGaA (Germany):

Fresenius SE & Co. KGaA (Germany) secured the top position in the home healthcare market in 2022, commanding a 4.7% market share. The company has cemented its leading status through robust distribution networks spanning North America, Europe, Latin America, Asia Pacific, and Africa. Fresenius boasts both direct and indirect distribution channels globally and pursues a blend of organic and inorganic growth strategies. Notably, the company expanded its home hemodialysis product offerings in Europe, the Middle East, and Africa in May 2020. Additionally, in August 2022, Fresenius acquired InterWell Health Brand (US), augmenting its expertise in kidney care value-based contracting and performance.

Abbott (US):

Abbott (US) captured a 3.9% share of the home healthcare market in 2022, leveraging its expanding global sales and distribution network. The company prioritizes research and development endeavors to develop and produce innovative products, enhancing its competitive edge. Abbott’s substantial investments in R&D fortify its product portfolio and distribution strategies, positioning it favorably for future growth. Moreover, Abbott pursues strategic acquisitions to bolster its market presence, exemplified by its collaboration with Insulet Corporation (US) in June 2020 to integrate Abbott’s CGM technology with Insulet’s Omnipod Horizon Automated Insulin Delivery System, providing tailored automated insulin delivery and care solutions for individuals with diabetes.

Global Home Healthcare Manufacturers:

Prominent manufacturers in the home healthcare industry include Philips Healthcare (Netherlands), Medtronic plc (Ireland), Omron Healthcare, Inc. (Japan), Fisher & Paykel Healthcare Limited (New Zealand), Bayer AG (Germany), Roche Diagnostics (Switzerland), Becton, Dickinson and Company (BD) (United States), among others. These companies specialize in offering a diverse array of home healthcare products and solutions, spanning medical devices, monitoring equipment, diagnostic tools, and other tailored healthcare products for home use.

Philips Healthcare (Netherlands):

Philips Healthcare leads the global home healthcare solutions market, offering an extensive range of medical devices and equipment designed to facilitate at-home health management. From sleep apnea therapy devices to remote patient monitoring solutions, Philips’ innovative offerings empower individuals to monitor and manage their health conditions conveniently.

Medtronic plc (Ireland):

Renowned for its medical technologies and solutions, Medtronic plc provides a wide array of home healthcare products aimed at enhancing patient outcomes and quality of life. With a focus on innovation and patient-centricity, Medtronic’s portfolio includes insulin pumps, continuous glucose monitoring systems, and other devices tailored for managing chronic conditions at home.

Omron Healthcare, Inc. (Japan):

A leading manufacturer of home healthcare devices, Omron Healthcare, Inc. emphasizes wellness promotion and disease prevention. Its product lineup encompasses blood pressure monitors, nebulizers, thermometers, and activity trackers, empowering individuals to monitor vital health parameters and make informed decisions about their health.

Fisher & Paykel Healthcare Limited (New Zealand):

Specializing in respiratory care products and sleep apnea therapy devices, Fisher & Paykel Healthcare Limited prioritizes patient comfort and compliance. Its offerings include humidification systems, nasal masks, and CPAP devices, tailored to meet diverse patient needs worldwide.

Bayer AG (Germany), Roche Diagnostics (Switzerland), Becton, Dickinson and Company (BD) (United States):

These global healthcare giants offer a wide range of consumer health products and medical devices for home use, spanning blood glucose meters, self-testing kits, insulin syringes, pen needles, lancets, and more, empowering individuals to manage their health conditions effectively at home.

Blog Tags
Blog Category

Leave a Reply